Integration of compound, target, and pathway data positioned IL-6 as a central mediator, interacting with MAPK1, MAPK3, MAPK14, PTGS2, and BCL2, genes associated with inflammation-induced insulin resistance and adipocyte dysfunction. This evidence concerns the gene MAPK1 and Insulin resistance.